Genprex, Inc.
GNPX
$3.43
-$0.11-3.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.80M | 1.75M | 1.32M | 1.15M | 2.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.48M | 4.49M | 3.52M | 3.35M | 4.68M |
| Operating Income | -4.48M | -4.49M | -3.52M | -3.35M | -4.68M |
| Income Before Tax | -4.45M | -4.46M | -3.79M | -3.80M | -4.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.45M | -4.46M | -3.79M | -3.80M | -4.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.45M | -4.46M | -3.79M | -3.80M | -4.67M |
| EBIT | -4.48M | -4.49M | -3.52M | -3.35M | -4.68M |
| EBITDA | -- | -- | -3.52M | -3.34M | -4.68M |
| EPS Basic | -9.40 | -14.12 | -39.55 | -109.91 | -185.30 |
| Normalized Basic EPS | -5.87 | -8.82 | -24.72 | -68.69 | -115.81 |
| EPS Diluted | -9.40 | -14.12 | -39.55 | -109.91 | -185.30 |
| Normalized Diluted EPS | -5.87 | -8.82 | -24.72 | -68.69 | -115.81 |
| Average Basic Shares Outstanding | 473.20K | 316.00K | 95.80K | 34.60K | 25.20K |
| Average Diluted Shares Outstanding | 473.20K | 316.00K | 95.80K | 34.60K | 25.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |